Carboprost trometamol in the management of the third stage of labor
- 1 September 1993
- journal article
- clinical trial
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 42 (3) , 247-250
- https://doi.org/10.1016/0020-7292(93)90219-m
Abstract
To compare carboprost trometamol with methylergometrine in managing the third stage of labor. One hundred and fifty parturient women were randomly assigned to use carboprost trometamol or methylergometrine immediately after delivery. Both the duration of the third stage and the mean blood loss were significantly less in the carboprost group than the methergine group (P < 0.001). Carboprost trometamol is a more potent uterotonic drug than methylergometrine. Reducing blood loss in parturient women is very important especially in cases where there is the likelihood of anemia.Keywords
This publication has 4 references indexed in Scilit:
- Maternal mortality in AssiutInternational Journal of Gynecology & Obstetrics, 1992
- PROPHYLACTIC USE OF 15(S)15 METHYL PGF2α, BY INTRAMUSCULAR ROUTE — A CONTROLLED CLINICAL TRIALActa Obstetricia et Gynecologica Scandinavica, 1988
- PROPHYLACTIC USE OF 15(S)15 METHYL PGF2α BY INTRAMUSCULAR ROUTE FOR CONTROL OF POSTPARTUM BLEEDING — A COMPARATIVE TRIAL WITH METHYLERGOMETRINEActa Obstetricia et Gynecologica Scandinavica, 1988
- The mechanism of prostaglandin action on the pregnant human uterusProstaglandins, 1979